Compound information
- Natural Products
- ZC675199
- Molecular Formula
- C18H24N2O6S
- Molecular Weight
- 396.135507488 g/mol
- Structure
-
- IUPAC Name
- (2R,4R)-1-[(2S)-2-(benzyloxycarbonylamino)-4-methylsulfanyl-butanoyl]-4-hydroxy-pyrrolidine-2-carboxylic acid
- InChI
- InChI=1S/C18H24N2O6S/c1-27-8-7-14(16(22)20-10-13(21)9-15(20)17(23)24)19-18(25)26-11-12-5-3-2-4-6-12/h2-6,13-15,21H,7-11H2,1H3,(H,19,25)(H,23,24)/t13-,14+,15-/m1/s1
- InChI Key
- TUZCGQBULDQMTL-QLFBSQMISA-N
- SMILES
- CSCC[C@H](NC(=O)OCc1ccccc1)C(=O)N1C[C@H](O)C[C@@H]1C(=O)O
- Source
- ZINC000004042886
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
| Property | Value | Property | Value |
|---|---|---|---|
| Heavy Atom Count | 27 | Ring Count | 2 |
| Heteroatom Count | 9 | Rotatable Bond Count | 8 |
| Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 3 |
| Topological Polar Surface Area | 116.17 Å2 | LogP | 1.147 |
| LogS | -2.881 | LogD | 0.314 |
Absorption
| Property | Value | Property | Value |
|---|---|---|---|
| Pgp inhibitor | 0.007 | Pgp substrate | 0.752 |
| HIA | 0.001 | F20 % | 0.99 |
| F30 % | 0.255 | Caco-2 | -6.16 |
| MDCK | -5.569 |
Distribution
| Property | Value | Property | Value |
|---|---|---|---|
| BBB Penetration | 0.003 | PPB | 72.505 |
| VD | 0.36 | Fu | 0.933 |
Metabolism
| Property | Value | Property | Value |
|---|---|---|---|
| CYP1A2 inhibitor | 0.003 | CYP1A2 substrate | 0.689 |
| CYP2A6 substrate | 0.613 | CYP2B6 substrate | 0.545 |
| CYP2C19 inhibitor | 0.046 | CYP2C19 substrate | 0.792 |
| CYP2C8 substrate | 0.68 | CYP2C9 inhibitor | 0.074 |
| CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.005 |
| CYP2D6 substrate | 0.618 | CYP2E1 substrate | 0.398 |
| CYP3A4 inhibitor | 0.01 | CYP3A4 substrate | 0.995 |
Excretion
| Property | Value | Property | Value |
|---|---|---|---|
| T1/2 | 0.875 | CL | 3.865 |
Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| hERG Blockers | 0.01 | Hepatotoxicity | 0.811 |
| Mutagenicity | 0.016 | Rat Oral Acute Toxicity | 0.043 |
| FDAMDD | 0.521 | Skin Sensitization | 0.003 |
| Carcinogenicity | 0.001 | Eye Corrosion | 0.004 |
| Eye Irritation | 0.237 | Respiratory Toxicity | 0.017 |
Environmental Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| Bioconcentration Factors | -0.831 | IGC50 | 1.881 |
| LC50FM | 2.624 | LC50DM | 4.382 |
Tox21 Pathway
| Property | Value | Property | Value |
|---|---|---|---|
| NR-AR | 0.503 | NR-AR-LBD | 0.436 |
| NR-AhR | 0.005 | NR-Aromatase | 0.024 |
| NR-ER | 0.416 | NR-ER-LBD | 0.371 |
| NR-PPAR-gamma | 0.421 | SR-ARE | 0.211 |
| SR-ATAD5 | 0.293 | SR-HSE | 0.161 |
| SR-MMP | 0.007 | SR-p53 | 0.067 |
Similar covalent drugs
No similar covalent drugs found for this compound.